Cancer risk after iodine-131 therapy for hyperthyroidism

Journal of the National Cancer Institute

Volumn 83, Issue 15, 1991, Pages 1072-1077

  Holm, Lars Erik ^a   Hall, Per ^a   Wiklund, Kerstin ^a   Lundell, Göran ^a   Berg, Gertrud ^b   Bjelkengren, Göran ^c   Cederquist, Ebbe ^c   Ericsson, Ulla Britt ^c   Hallquist, Arne ^d   Larsson, Lars Gunnar ^d   Lidberg, Monika ^e   Lindberg, Sture ^b   Tennvall, Jan ^c   Wicklund, Harriet ^f   Boice, John D ^g  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^e STOCKHOLM SÖDER HOSPITAL   (Sweden)

^f UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^g NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131;

ADULT; AGED; ARTICLE; BRAIN CANCER; CANCER RISK; FEMALE; HUMAN; HYPERTHYROIDISM; KIDNEY CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; STOMACH CANCER;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMAN; HYPERTHYROIDISM; IODINE RADIOISOTOPES; LEUKEMIA; MALE; MIDDLE AGE; NEOPLASMS; RISK FACTORS; SUPPORT, U.S. GOV'T, P.H.S.; SWEDEN;

EID: 0025851344     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/83.15.1072     Document Type: Article

References (25)

1. Sanger EL, Thoma Ge, Tompkins EA: Incidence of leukemia following treatment of hyperthyroidism. Preliminary report of the Cooperative Thyrotoxicosis Therapy Follow-up Study. JAMA 205: 855-862, 1968
2. Dobyns BM, Sheune GE, Workman JB, Et Al: Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: A report of the Cooperative Thyrotoxicosis Therapy Follow-up Study. J Clin Endocrinol Metab 38:976-998, 1974
3. Holm LE, Dahlqvist I, Israelsson A, Et Al: Malignant thyroid tumors after iodine-131 therapy. A retrospective cohort study. N Engl J Med 303:188-191, 1980
4. Hoffman DA: Late effects of I-I3I therapy in the United States. In Radiation Carcinogenesis: Epidemiology and Biological Significance (Boice JD Jr, Fraumeni JF Jr, eds). New Yoric: Raven Press, 1984, pp 273-280
5. Holm LE: Malignant disease following iodine-131 therapy in Sweden. In Radiation Carcinogenesis: Epidemiology and Biological Significance (Boice JD Jr, Fraumeni JF Jr, eds). New York: Raven Press, 1984, pp 263-272
6. Goldman MB, Maloof F, Monson RR, et al: Radioactive iodine therapy and breast cancer: A follow-up study of hyperthyroid women. Am J Epidemiol 127: 969-980, 1988
7. International Commission on Radiological Protection: Radiation Dose to Patients from Radiopharmaceuticals. ICRP Publ No. 53. Oxford: Pergamon Press, 1988, pp 259-277
8. Edmonds CJ, Smith T: The long-term hazards of the treatment of thyroid cancer with radioiodine. Br J Radiol 59: 45-51, 1986
9. Shimizu Y, Kato H: Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 1. Comparison of risk coefficients for site-specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses. Radiat Res 118: 502-524, 1989
10. Boice JD Jr, Engholm G, Kleinerman RA, et al: Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res 116: 3-55, 1988
11. MacMahon B: Some recent issues in low-exposure radiation epidemiology. Environ Health Perspect 81:131-135, 1989
12. Stevens W, Thomas DC, Lyon JL, et al: Leukemia in Utah and radioactive fallout from the Nevada test site. A case-control study. JAMA 264:585-591, 1990
13. Boice JD Jr, Preston D, Davis FG, et al: Frequent chest x-ray fluoroscopy and breast cancer among tuberculosis patients in Massachusetts. Radiat Res 125:214-222, 1991
14. Goldman MB, Monson RR, Maloof F: Cancer mortality in women with thyroid disease. Cancer Res 50:2283-2289, 1990
15. Hoffman DA, McConahey WM: Breast cancer following iodine-131 therapy for hyperthyroidism. JNCI 70:63-67, 1983
16. Tucker MA, Morris Jones P, Boice JD Jr, et al: For Late Effects Study Group: Therapeutic radiation at a young age linked to secondary thyroid cancer. Cancer Res 51:2885-2888, 1991
17. de Vathaire F, Francchs P, Schweisguth O, et al: Irradiated neuroblastoma in childhood as potential risk factor for subsequent thyroid tumour. Lancet 2:455, 1988
18. Cuzick J: Radiation-induced myelomatosis. N Engl J Med 304:204-210, 1981
19. National Council on Radiation Protection and Measurements: Influence of dose and its distribution in time on dose-response relationships for low-LET radiations. NCRP Report No. 64. Washington, D.C: NCRP, 1980
20. United Nations Scientific Committee on the Effects of Atomic Radiation: Genetic and Somatic Effects of Ionizing Radiation. 1986 Report to the General Assembly, with Annexes. New York: United Nations, 1986
21. Wang ZY, Boice JD Jr, Wei LX, et al: Thyroid nodularity and chromosome aberrations among women in areas of high background radiation in China. J Natl Cancer Inst 82:478-485, 1990
22. Holm LE, Wiklund KE, Lundell GE, et al: Thyroid cancer after diagnostic doses of iodine-131: A retrospective cohort study. J Natl Cancer Inst 80:1132-1138, 1988
23. Davis FG, Boice JD Jr, Hrubec Z, et al: Cancer mortality in a radiation- exposed cohort of Massachusetts tuberculosis patients. Cancer Res 49:6130-6136, 1989
24. Boice JD Jr: Studies of atdmic bomb survivors. JAMA 264:622-623, 1990
25. Upton AC: Carcinogenic effects of low-level ionizing radiation. J Natl Cancer Inst 82:448-449, 1990